Tacrolimus toxicity due to enzyme inhibition from ritonavir

Tacrolimus is commonly used for immunosuppression in patients following solid organ transplantation. For transplant patients with COVID-19 infection, early treatment is indicated due to the risk of progression to severe disease. However, the first line agent, nirmatrelvir/ritonavir, has multiple dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Snee, Isabel, Drobina, Joshua, Mazer-Amirshahi, Maryann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159930/
https://www.ncbi.nlm.nih.gov/pubmed/37173153
http://dx.doi.org/10.1016/j.ajem.2023.04.045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159930/
https://www.ncbi.nlm.nih.gov/pubmed/37173153
http://dx.doi.org/10.1016/j.ajem.2023.04.045

Ejemplares similares